Biomarkers Market Research Reports & Industry Analysis
Biomarkers are measurable indicators, such as molecules or genetic mutations, that provide information about a biological process, condition, or disease in the body. As healthcare evolves, it's important to grasp the impact and unique dynamics of this industry. At MarketResearch.com, we understand the need for reliable data on this sector. Our biomarkers market research reports provide a comprehensive and informative analysis, empowering you to navigate this dynamic industry with greater confidence.
Biomarkers Industry Insights
- Our research covers diverse markets so you can quickly and easily find research on segments big and small.
- Through our platform, you can access essential data to drive strategic decisions, from biomarkers market sizing and growth projections to key drivers and challenges.
- Use our research to better understand products under development, market trends, competitor analysis, and leading players.
Harnessing MarketResearch.com's Expertise
For more than twenty years, MarketResearch.com has been a leader in the field of market research, serving a diverse clientele that includes top investment banks, management consulting firms, and multinational corporations. We are known for providing reliable insights and offer a centralized platform with access to reports from numerous firms. In addition, our research specialists are available to provide expert guidance and support every step of the way.
Biomarkers Industry Research & Market Reports
-
Global Rare Biomarkers Market Growth (Status and Outlook) 2024-2030
... a CAGR of %from 2024 to 2030. LPI (LP Information)' newest research report, the “Rare Biomarkers Industry Forecast” looks at past sales and reviews total world Rare Biomarkers sales in 2022, providing a comprehensive analysis ... Read More
-
Cardiac Biomarkers
... at a CAGR of 7.4% over the analysis period 2023-2030. Troponins (T & I), one of the segments analyzed in the report, is expected to record a 8.6% CAGR and reach US$11.2 Billion by the ... Read More
-
Cancer/Tumor Profiling Market Report by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), Technology (Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Microarray, and Others), Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032
... Technique (Genomics, Proteomics, Epigenetics, Metabolomics), Application (Personalized Medicine, Diagnostics, Biomarker Discovery, Prognostics, and Others), and Region 2024-2032 The global cancer/tumor profiling market size reached US$ 11.5 Billion in 2023. Looking forward, IMARC Group expects the ... Read More
-
Biomarkers
... of 13.6% over the analysis period 2023-2030. Safety Biomarkers, one of the segments analyzed in the report, is expected to record a 13.8% CAGR and reach US$89.8 Billion by the end of the analysis period. ... Read More
-
Renal Biomarkers Market Report by Biomarker Type (Functional Biomarker, Up-regulated Protein, and Others), Diagnostic Technique (Enzyme-linked Immunosorbent Assay (ELISA), Particle-enhanced Turbidimetric Immunoassay (PETIA), Colorimetric Assay, Chemiluminescent Enzyme Immunoassay (CLIA), Liquid Chromatography Mass Spectrometry (LC-MS)), End User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032
... User (Hospital, Diagnostic Laboratory, and Others), and Region 2024-2032 The global renal biomarkers market size reached US$ 1.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2032, ... Read More
-
Global Biomarker Test Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Most healthcare experts use analysis assessments to make clear and aid their scientific choice making. ... Read More
-
Metabolomics Market (Product and Service Type: Metabolomic Instruments, and Bioinformatics Tools and Services; and Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Personalized Medicine, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Forecast, 2024-2034 Metabolomics Market – Scope of Report TMR’s report on the global metabolomics market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of ... Read More
-
Asia-Pacific Clinical Biomarkers Market - Analysis and Forecast, 2023-2033
... 2033, growing at a CAGR of 9.27% between 2023 and 2033. Clinical biomarkers are quantifiable biological parameters that aid in understanding the progression and early diagnosis of diseases. These biomarkers, particularly molecular ones, offer new ... Read More
-
Global Cancer Biomarkers Detection Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Cancer Biomarkers Detection is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Predictive Diagnostics Market - 2024-2031
... period 2024-2031. Predictive diagnostics employs customized data and a suite of diagnostic devices to deliver precise, real-time insights and identify potential problems. By integrating molecular innovations, genomics applications, and rapid R&D processes, predictive diagnostics can ... Read More
-
Global Biomarker Testing Market - 2024-2031
... period 2024-2031. Biomarker testing is the use of a laboratory test to measure biomarkers found in blood, other body fluids, or tissue. Biomarker testing can be somatic or germline. Biomarker testing is also done to ... Read More
-
2024 Global: Neurological Biomakers Market - Innovative Markets Forecast (2030) report
... 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 to 2030 using regression ... Read More
-
2024 Global: Non-Alcoholic Steatohepatitis (Nash) Biomarkers Market - Innovative Markets Forecast (2030) report
... data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project the product market size nationally and by regions for 2019 ... Read More
-
Global Vocal Biomarker Market 2024 by Company, Regions, Type and Application, Forecast to 2030
... CAGR of 12.0% over the analysis period. Vocal patterns have been used by clinical psychologists and psychoanalysts for analyzing personality traits of patients, and helping creation of headway in clinical and medical investigations. Recent breakthroughs ... Read More
-
Global Liquid Biopsy Market 2024-2028
... market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the ... Read More
-
Cardiac Biomarkers Market, By Product Type (Myocardial Muscle Creatine Kinase, Myoglobin, Troponins, Brain Natriuretic Peptide or NT-proBNP, Ischemia-modified Albumin, and Others), By Application (Myocardial Infarction, Congestive Heart Failure, Acute Coronary Syndrome, Atherosclerosis, and Others), By Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Location of Testing (Laboratory Testing and Point of Care Testing), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Cardiac biomarkers refer to proteins that are present in blood when the ... Read More
-
Theranostics Market by Product (Software and Services, Radiopharmaceuticals, IVD/Biomarker Screening, Diagnostic Imaging), Application, End User, and Geography - Global Industry Analysis, Opportunities and Forecast up to 2030
... was valued at $2.39 billion in 2024 and is projected to reach $5.77 billion by 2030, growing at a CAGR of 15.8% during the forecast period. Theranostics Market Overview Theranostics is a cutting-edge field of ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Neurological biomarkers help in objectively measuring and evaluating normal biological and pathogenic processes. These aid in detecting neurological ... Read More
-
2024 Malaysia Tumor Marker Diagnostics Market Opportunities - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... Barriers and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. Highlights Five-year ... Read More
-
Global Biomarkers Competitive Landscape Professional Research Report 2024
... organism. They can be found in bodily fluids, tissues, or other biological samples and can provide valuable information about the presence, progression, or severity of a disease, as well as the efficacy of a treatment ... Read More
-
Exosome Research Market Assessment, By Product and Service [Kits and Reagents, Instruments, Services], By Indication Type [Cancer, Neurodegenerative Diseases, Cardiovascular Diseases, Infectious Diseases, Others], By Application Type [Biomarkers, Vaccine Development, Tissue Regeneration, Others], By End-user [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F
... [Pharmaceutical and Biotechnological Companies, Hospitals and Clinical Testing Laboratories, Academic and Research Institutes], By Region, Opportunities and Forecast, 2017-2031F Global exosome research market is projected to witness a CAGR of 17.37% during the forecast period ... Read More
-
Global Digital Biomarker Competitive Landscape Professional Research Report 2024
... track health-related information, disease progression, treatment outcomes, and overall well-being. Digital biomarkers have the potential to provide continuous, real-time data, allowing for more comprehensive insights compared to traditional sporadic clinical assessments. They can include parameters ... Read More
-
Global Commercializing Biomarkers in Therapeutic and Diagnostic Applications Competitive Landscape Professional Research Report 2024
... that can be used in various medical contexts. Biomarkers are measurable indicators found in biological samples, such as blood, urine, or tissue, that can signal the presence or progression of diseases or provide insights into ... Read More
-
Global Neurological Biomarkers Competitive Landscape Professional Research Report 2024
... physiological, biochemical, or imaging-based measurements that are associated with normal neurological function or specific neurological conditions or diseases. Examples of neurological biomarkers include specific proteins or molecules found in cerebrospinal fluid or blood, abnormalities or ... Read More
-
Global PD-L1 Biomarker Testing Competitive Landscape Professional Research Report 2024
... on the surface of cancer cells. It plays a crucial role in the field of cancer immunotherapy, particularly in the treatment of solid tumors with immune checkpoint inhibitors. The test involves analyzing tissue samples from ... Read More
Research Assistance
